Progressive Multiple Sclerosis: The Treatment Gap

Nature - United Kingdom
doi 10.1038/nature11108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Ocrelizumab in the Treatment of Primary-Progressive Multiple Sclerosis

Medical Council
2018English

New Age for Progressive Multiple Sclerosis

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Exercise Training in Progressive Multiple Sclerosis

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

Recognizing the Diversity Gap in Multiple Sclerosis

Multiple Sclerosis
Neurology
2019English

Restoring Function in Progressive Multiple Sclerosis

The Lancet Neurology
Neurology
2019English

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

Frontiers in Neurology
Neurology
2017English

Masitinib Treatment in Patients With Progressive Multiple Sclerosis: A Randomized Pilot Study

BMC Neurology
MedicineNeurology
2012English

Differential Diagnosis of Primary Progressive Multiple Sclerosis

Clinical pharmacology and therapy
2018English

Development of a Sensitive Outcome for Economical Drug Screening for Progressive Multiple Sclerosis Treatment

Frontiers in Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy